Efgartigimod
argenx
['ct041']
do we have a potential new therapeutic agent for itp? dr catherine broome presenting advance phase 3 trial data for efgartigimod in adults with itp #ash22 
Pediatric Hematologist @CCMC, Asso. PD for the fellowship, and sometimes Gryffindor but sometimes Ravenclaw